App-Quantinova.ai

Application of biomarkers measured in serum reflecting specific tissue remodeling and dysregulation for lung cancer and other lung pathologies.

Nicholas Willumsen - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Better Performance of Flow-FISH in Comparison to qPCR As a Diagnostic Test for Telomere Diseases

Fernanda Gutierrez-Rodrigues - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Idiopathic pulmonary fibrosis

N/A

Extrahematopoietic Manifestations of Telomere Syndromes

Mary Armanios - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

N/A

Mesenchymal Stem Cells Reduce Endoplasmic Reticulum (ER) Stress and Correct Inappropriate Epithelial Mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1

Shinya Ohkouchi - American Society of Gene & Cell Therapy (ASGCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Liraglutide improves surfactant protein-B production and reduces right ventricular hypertrophy in a rat model of intersitial pulmonary fibrosis

Marina Romani Perez - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Streptozotocin

Lung Transplantation in Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Single Center Experience

L. Mudambi - International Society for Heart & Lung Transplantation (ISHLT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Pulmonary Vein Stenosis Complicated By Early Thrombosis Post Single Lung Transplant

A. Daly - International Society for Heart & Lung Transplantation (ISHLT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

A Comparison of the Clinical Features and Natural History of Autoimmune Interstitial Lung Disease Vs. Idiopathic Pulmonary Fibrosis

Sandra Chartr - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Interstitial Lung Disease in Patients with Anti-PM-Scl Antibody

Hiromichi Tamaki - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Lysyl Oxidase Induces Fibrosis Via Upregulation of IL-6 and Serves As a Biomarker to Monitor Response to Therapy

Tetsuya Nishimoto - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

DE-074

Pulmonary Arterial Hypertension in Patients with Anti-PM-Scl Antibody

Hiromichi Tamaki - American College of Rheumatology (ACR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Idiopathic pulmonary fibrosis

N/A

A New Enzyme-Linked Immunosorbent Assay System for Detecting Autoantibodies to Aminoacyl-tRNA Synthetases: Clinical Usefulness in Myositis and Interstitial Pneumonia

Ran Nakashima - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

N/A

Anti-Cyclic Citrullinated Peptide Antibodies in Idiopathic Pulmonary Fibrosis Are Not Citrulline-Specific: Implications for the Pathogenesis of Rheumatoid Arthritis

Elena B. Lugli - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

citrulline

Important Prognostic Factor in Rheumatoid Arthritis Patients with Interstitial Lung Disease Is Not Usual Interstitial Pneumonia Pattern but Interstitial Lung Disease Extent On Chest High-Resolution Computed Tomography

Hwajeong Lee - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

Myositis-Associated Usual Interstitial Pneumonia Has Better Survival Than Idiopathic Pulmonary Fibrosis

Christine McBurney - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

N/A

Rheumatoid Arthritis-Associated Interstitial LUNG Disease: Clinical Spectrum of A Large Cohort From A Respiratory Referral Center

Joshua J. Solomon - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

Wisp-1 Neutralization Reduces Gvhd-Induced Skin Fibrosis by Altering TSLP-OX40L Axis-Dependent Th2 Responses

Raphael Lemaire - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

OX40L

A New Pathogenic Role Of BAFF As a Critical Mediator Of Skin and Lung Fibrosis In Experimental Bleomycin-Induced Pulmonary Fibrosis, Systemic Sclerosis and Idiopathic Pulmonary Fibrosis

Antoine Francois - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Bleomycin

The Role Of STAT-3 In The Development Of Pulmonary and Dermal Fibrosis

Mesias Pedroza - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Bleomycin

Anti-Citrullinated Heat Shock Protein 90 Antibodies Identified in Bronchoalveolar Lavage Fluid Are a Marker of Lung-Specific Immune Responses

Lisa Harlow - American College of Rheumatology (ACR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Doyle

Filters

914 Abstracts